Compare NGS & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NGS | ANGO |
|---|---|---|
| Founded | 1998 | 1988 |
| Country | United States | United States |
| Employees | 245 | N/A |
| Industry | Oilfield Services/Equipment | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 475.1M | 462.0M |
| IPO Year | 2006 | 2004 |
| Metric | NGS | ANGO |
|---|---|---|
| Price | $37.62 | $10.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $39.00 | $19.33 |
| AVG Volume (30 Days) | 83.0K | ★ 324.2K |
| Earning Date | 01-01-0001 | 04-07-2026 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | ★ 260.53 | 81.92 |
| EPS | ★ 1.25 | N/A |
| Revenue | $156,742,000.00 | ★ $291,010,000.00 |
| Revenue This Year | $9.83 | $9.11 |
| Revenue Next Year | $14.49 | $4.94 |
| P/E Ratio | $30.09 | ★ N/A |
| Revenue Growth | ★ 29.36 | 10.17 |
| 52 Week Low | $16.73 | $8.27 |
| 52 Week High | $39.67 | $13.99 |
| Indicator | NGS | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 55.47 | 43.73 |
| Support Level | $32.52 | $10.37 |
| Resistance Level | $39.67 | $11.03 |
| Average True Range (ATR) | 1.30 | 0.33 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 44.51 | 24.14 |
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.